This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...